Bempedoic acid as an ATP citrate lyase inhibitor, which reduces low-density lipoprotein (LDL) cholesterol levels [92], has been demonstrated to inhibit hepatocellular carcinoma in mice [84]. Here, ACLY is linked to hepatocellular carcinoma.